MAPT and central nervous system disorder: In addition, a PROTAC, which contained the Tau recognition motif YQYQDATADEQG, a CPP, and the VHL binding motif ALAPYIP was also reported to target the degradation of Tau protein in the mouse brain, [114]; the availability of this multifunctional peptide marks a new era in the treatment of central nervous system diseases.